Related Experiment Video
Updated: May 12, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
Genomic meta-analysis of growth factor and integrin pathways in chronic kidney transplant injury
Amrita Dosanjh1, Elizabeth Robison, Tony Mondala
1Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA.
Background:
Chronic Allograft Nephropathy (CAN) is a clinical entity of progressive kidney transplant injury. The defining histology is tubular atrophy with interstitial fibrosis (IFTA). Using a meta-analysis of microarrays from 84 kidney transplant biopsies, we revealed growth factor and integrin adhesion molecule pathways differentially expressed and correlated with histological progression. A bioinformatics approach mining independent datasets leverages new and existing data to identify correlative changes in integrin and growth factor signaling pathways.
Results:
Analysis of CAN/IFTA Banff grades showed that hepatocyte growth factor (HGF), and epidermal growth factor (EGF) pathways are significantly differentially expressed in all classes of CAN/IFTA. MAPK-dependent pathways were also significant. However, the TGFβ pathways, albeit present, failed to differentiate CAN/IFTA progression. The integrin subunits β8, αv, αμ and β5 are differentially expressed, but β1, β6 and α6 specifically correlate with progression of chronic injury. Results were validated using our published proteomic profiling of CAN/IFTA.
Conclusions:
CAN/IFTA with chronic kidney injury is characterized by expression of distinct growth factors and specific integrin adhesion molecules as well as their canonical signaling pathways. Drug target mapping suggests several novel candidates for the next generation of therapeutics to prevent or treat progressive transplant dysfunction with interstitial fibrosis.
Insights
Chronic Allograft Nephropathy (CAN) involves kidney transplant injury. Key growth factors and integrins correlate with disease progression, offering new therapeutic targets for kidney fibrosis.
Area of Science:
- Nephrology
- Transplantation Immunology
- Bioinformatics
Background:
- Chronic Allograft Nephropathy (CAN) is a major cause of kidney transplant failure, histologically defined by interstitial fibrosis and tubular atrophy (IFTA).
- Understanding the molecular pathways driving CAN progression is crucial for developing effective treatments.
- Previous studies suggested a role for growth factors and adhesion molecules in transplant injury.
Purpose of the Study:
- To identify differentially expressed pathways and molecules associated with the progression of Chronic Allograft Nephropathy (CAN) and interstitial fibrosis and tubular atrophy (IFTA).
- To leverage bioinformatics and meta-analysis to uncover novel correlative changes in integrin and growth factor signaling pathways in kidney transplant biopsies.
- To explore potential therapeutic targets for preventing or treating progressive kidney transplant dysfunction.
Main Methods:
- Conducted a meta-analysis of microarrays from 84 kidney transplant biopsies with varying grades of CAN/IFTA.
- Employed bioinformatics approaches to mine independent datasets for correlative changes in signaling pathways.
- Validated findings using proteomic profiling of CAN/IFTA.
Main Results:
- Hepatocyte growth factor (HGF) and epidermal growth factor (EGF) pathways, along with MAPK-dependent pathways, were significantly differentially expressed in all CAN/IFTA grades.
- Specific integrin subunits (β8, αv, αμ, β5) were differentially expressed, while others (β1, β6, α6) correlated with the progression of chronic kidney injury.
- TGFβ pathways were present but did not differentiate CAN/IFTA progression.
Conclusions:
- CAN/IFTA is characterized by the distinct expression of specific growth factors and integrin adhesion molecules and their signaling pathways.
- The study identified novel molecular targets for next-generation therapeutics aimed at preventing or treating progressive kidney transplant dysfunction.
- Target mapping suggests potential drug candidates for managing interstitial fibrosis in kidney allografts.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Intracellular Signaling Affects Focal Adhesions
Some...
Kidney Transplant I: Introduction
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Mitogens and the Cell Cycle
